GAM
AXNX

Grandview Asset Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Grandview Asset Management’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-100
Closed -$6K – 506
2021
Q1 		$6K Buy
+100
New +$5.44K ﹤0.01% 380

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Grandview Asset Management's AXNX Position: Q2 2021 in Review

Grandview Asset Management sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2021, closing a stake of 100 shares — an estimated $6K sold.

Grandview Asset Management first reported a position in AXNX in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 177 funds tracked by Wall St. Rank hold AXNX as of Q2 2021.

  • Grandview Asset Management reported no remaining Axonics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Grandview Asset Management sold 100 Axonics, Inc. Common Stock shares in Q2 2021, an estimated $6K.
  • Grandview Asset Management first reported a position in Axonics, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Grandview Asset Management's Axonics, Inc. Common Stock position peaked at $6K in Q1 2021.
  • 177 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2021.

Based on Grandview Asset Management's 13F filing for Q2 2021, filed 21 Jul 2021.